Dicerna Pharmaceuticals, Inc. (NASDAQ: DRNA), a leader in the development of RNAi-based therapeutics, today announced that the Company will release its third-quarter 2014 financial results before market open on Thursday, November 6, 2014.
Management will conduct a conference call at 8:30 a.m. (EST) that day, to discuss the Company's financial results and provide a general business update.
Help employers find you! Check out all the jobs and post your resume.
Management will conduct a conference call at 8:30 a.m. (EST) that day, to discuss the Company's financial results and provide a general business update.
Help employers find you! Check out all the jobs and post your resume.
